Combination vaccines
David Ag Skibinski1, Barbara C Baudner, Manmohan Singh
1Novartis Vaccines, Via Fiorentina 1, Siena, Italy.
Insights
Combination vaccines like DTaP, polio, Hib, and HepB have protected children for decades. Developing these vaccines presented challenges, but they improved immunization compliance by reducing shots.
Area of Science:
- Pediatric immunology
- Vaccine development
- Public health
Background:
- Combination vaccines, including diphtheria, tetanus, pertussis (DTaP), inactivated polio, Haemophilus influenzae type b (Hib), and hepatitis B (HepB), are crucial for pediatric immunization.
- These combination vaccines have significantly increased immunization compliance by reducing the number of injections required.
- The evolution of combination vaccines has faced several hurdles.
Purpose of the Study:
- To review the challenges encountered during the development of pediatric combination vaccines.
- To discuss the future directions and prospects for combination vaccine technology.
Main Methods:
- Literature review of historical and current combination vaccine development.
- Analysis of immunological responses and safety profiles.
- Examination of immunization schedule integration and compliance data.
Main Results:
- Early combination vaccines faced challenges such as reduced immune response to Hib vaccine and scheduling complexities for HepB vaccine.
- Improvements in vaccine safety profiles for DTaP components were necessary.
- Successful integration of multiple antigens into single vaccine products has streamlined pediatric immunization schedules.
Conclusions:
- Combination vaccines have been instrumental in enhancing pediatric immunization coverage.
- Overcoming developmental challenges has led to more effective and compliant vaccination strategies.
- Future research will likely focus on further optimizing safety, efficacy, and the number of antigens in combination vaccines.
Abstract:
The combination of diphtheria, tetanus, and pertussis vaccines into a single product has been central to the protection of the pediatric population over the past 50 years. The addition of inactivated polio, Haemophilus influenzae, and hepatitis B vaccines into the combination has facilitated the introduction of these vaccines into recommended immunization schedules by reducing the number of injections required and has therefore increased immunization compliance. However, the development of these combinations encountered numerous challenges, including the reduced response to Haemophilus influenzae vaccine when given in combination; the need to consolidate the differences in the immunization schedule (hepatitis B); and the need to improve the safety profile of the diphtheria, tetanus, and pertussis combination. Here, we review these challenges and also discuss future prospects for combination vaccines.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccinations
Cross-reactivity
Smallpox
Vaccine Production


